N. Hillery

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

R. Garfein, T. Ganiats, F. Valafar, 2014, Trials.

Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.

R. Garfein, T. Ganiats, F. Valafar, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance

R. Colman, C. G. Cooney, D. Catanzaro, 2020, Journal of Clinical Microbiology.

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis

R. Garfein, F. Valafar, T. Victor, 2015, PloS one.

Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder

E. Groessl, S. Tally, N. Hillery, 2018, Journal of managed care & specialty pharmacy.

Cost analysis of rapid diagnostics for drug-resistant tuberculosis

R. Garfein, T. Ganiats, T. Victor, 2018, BMC Infectious Diseases.

Cost-Effectiveness of Humidified High-Flow Therapy (HHFT) for COPD Patients on Long-Term Oxygen Therapy

E. Groessl, S. Tally, N. Hillery, 2023, ClinicoEconomics and outcomes research : CEOR.

Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort

R. Colman, A. Catanzaro, V. Crudu, 2023, Journal of clinical microbiology.